Eske Willerslev is an evolutionary geneticist. He is particularly known for sequencing the first ancient human genome and establishing the field of environmental DNA, where modern and ancient DNA from higher plants and animals are obtained directly from environmental samples.
Willerslev was born in Denmark in 1971. After spending his youth as explorer and fur trapper in Siberia, he established the first ancient DNA laboratory in Denmark and obtained his DSc at University of Copenhagen in 2004. At the age of 33, Willerslev became Full Professor at University of Copenhagen - the youngest in Denmark at the time.
Willerslev has been visiting researcher at the MD Anderson Cancer Research Centre in Austin, Texas, independent Welcome Trust Fellow at Oxford, have been Visiting Professor at Oxford University, and a Miller Visiting Professor at UC Berkeley.
Read more at University of Copenhagen
Watch Why Human History Teaches us to Travel | Eske Willerslevs TEDxTalk
Awaiting final confirmation
I am a Professor in computer based systems at DTU Compute at the Technical University of Denmark and Head of the section on Embedded Systems Engineering. I am also Deputy Director of DTU Compute.
My research interests include design of embedded computer systems. In particular system-level modeling and analysis of multiprocessor systems, including RTOS modeling and hardware/software codesign. I am generally interested in design methodologies (including CAD tools) and implementations of embedded systems, covering areas of adaptable systems, wireless sensor networks and biochips.
I have done ethnographic PhD research on Danish hygge and its cultural basis in conceptions of home, togetherness and family life.
Including how it influences the consumption of leisure, hospitality, food and drinks.
Fatima Al-Zahraa Al Atraktchi is a qualified nano-physicist and autodidact molecular biologist, with a special interest in biomedicine. Among other things, she has developed a revolutionary method for detecting bacterial infections and has also proven that, in the vast majority of cases, patients who are clinically described as being free from bacteria after treatment are actually still infected.
Fatima is described as outstandingly intelligent, ambitious, focused, disciplined and energetic. She had already published eight articles in internationally reputable journals before she submitted her PhD, and she had a number of finished manuscripts ready for submission.
Watch Hacking into the secret communication... of bacteria | Fatima AlZahra’a Alatraktchis TEDxTalk
I am Associate Professor in medical humanities at the The Novo Nordisk Foundation Center for Basic Metabolic Research and at the Medical Museion in Copenhagen.
My work is split evenly between practical science communication (mainly curating exhibitions, most recently the exhibition Mind the Gut, winner of The Bikuben Foundation Exhibition Award Vision 2015) and theoretical research.
My research interest is focused on issues surrounding presence, embodiment, aesthetics and what it means to be human in a post-genomic world.
Annette has over 30 years experience in Laboratory Medicine, 20 years of which has been as Director of Weqas. Annette is the Clinical Lead for Point of Care Testing (PoCT) at Cardiff and Vale University Health Board, represents PoCT in Welsh Government Advisory Committees and is chair of the “All Wales” PoCT Coordinators Group.
Sverre Sandberg is a MD, PhD and specialist in laboratory medicine. He is director of Noklus, a Norwegian organisation for quality improvement of primary care laboratories which serves about 3000 users of POC equipement outside hospitals (GP offices, nursing homes, oil platforms etc) and chair of SKUP, Scandinavian Evaluation of Laboratory Equipment for Primary Health Care.
He is director of the Norwegian Porphyria Centre (NAPOS). He is professor at the University of Bergen. From 2002–2012 he was director of Laboratory of Clinical Biochemistry at Haukeland University Hospital in Bergen.
Read more at the homepage of NOKLUS.
My research covers translational and basic research in the field of type 1 diabetes (T1D) pathogenesis. My prime objective is to investigate the cellular and molecular mechanisms involved in immune-mediated beta cell failure leading to T1D.
By understanding the genes, proteins, and factors affecting T1D risk at the beta cell level, the long-term perspective is to circumvent beta cell destruction in individuals at risk for T1D.